Leuprolide Acetate Treatment for Ovarian Cysts in Breast Cancer Patients Under Tamoxifen Therapy
OBJECTIVE: The aim of this study is to evaluate the outcomes of gonadotropin-releasing hormone agonist treatment for ovarian cysts, which are developed during tamoxifen use due to breast cancer. STUDY DESIGN: This was a retrospective cohort study including the patients who were under tamoxifen tr...
Saved in:
Main Authors: | Şafak Yılmaz Baran, Gulsen Dogan Durdag, Songul Alemdaroglu, Sirin Aydin, Husnu Celik |
---|---|
Format: | Article |
Language: | English |
Published: |
Medical Network
2022-12-01
|
Series: | Gynecology Obstetrics & Reproductive Medicine |
Subjects: | |
Online Access: | https://gorm.com.tr/index.php/GORM/article/view/1320 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Different Timing of Adjuvant Low Dose hCG and GnRH Agonist Trigger Protocol, in OHSS High-Risk Patient with Peak E2 Level <4000 pg/mL
by: Emilija Zoran Petanovska Kostova, et al.
Published: (2020-12-01) -
Ectopic adrenal gland tissue in the luteal cyst of ovary: A case report
by: Limei Wang, et al.
Published: (2025-02-01) -
Efficacy of leuprolide acetate versus triptorelin pamoate administered every 3 months for treatment of central precocious puberty
by: Thanaporn Thaneetrakool, et al.
Published: (2025-01-01) -
Bilosomal Co-Encapsulated Tamoxifen and Propranolol for Potentiated Anti-Breast Cancer Efficacy: In Vitro and In Vivo Investigation
by: Toka T. Elebyary, et al.
Published: (2025-01-01) -
LINC00626 drives tamoxifen resistance in breast cancer cells by interaction with UPF1
by: Hui Yuan, et al.
Published: (2025-01-01)